EGM
NWBO

Engineers Gate Manager’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Engineers Gate Manager’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-55,150
Closed -$548K – 1203
2015
Q2 		$548K Buy
55,150
+16,344
+42% +$143K 0.05% 595
2015
Q1 		$286K Buy
+38,806
New +$261K 0.04% 721

Other funds holding NWBO

WIM
Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Engineers Gate Manager's NWBO Position: Q3 2015 in Review

Engineers Gate Manager sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2015, closing a stake of 55,150 shares — an estimated $548K sold.

Engineers Gate Manager first reported a position in NWBO in Q1 2015 and held it in 2 quarters. The position peaked at $548K in Q2 2015. 79 funds tracked by Wall St. Rank hold NWBO as of Q3 2015.

  • Engineers Gate Manager reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2015 after selling out during the quarter.
  • Engineers Gate Manager sold 55,150 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2015, an estimated $548K.
  • Engineers Gate Manager first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2015 and held it in 2 quarters.
  • Engineers Gate Manager's Northwest Biotherapeutics, Inc. Common stock position peaked at $548K in Q2 2015.
  • 79 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2015.

Based on Engineers Gate Manager's 13F filing for Q3 2015, filed 16 Nov 2015.